Skye Bioscience, Inc. financial data

Symbol
SKYE on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 10 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 598% % -28%
Debt-to-equity 20% % 43%
Return On Equity -144% % -299%
Return On Assets -120% % -280%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 33,378,764 shares 7.8%
Common Stock, Shares, Outstanding 33,378,139 shares 7.8%
Entity Public Float $129,530,291 USD -42%
Common Stock, Value, Issued $33,379 USD 7.8%
Weighted Average Number of Shares Outstanding, Basic 39,662,664 shares 8.7%
Weighted Average Number of Shares Outstanding, Diluted 39,662,664 shares 8.7%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $15,801,686 USD -11%
Operating Income (Loss) $58,163,565 USD -93%
Nonoperating Income (Expense) $2,244,151 USD -38%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $55,919,414 USD -111%
Income Tax Expense (Benefit) $5,400 USD -46%
Net Income (Loss) Attributable to Parent $55,924,814 USD -111%
Earnings Per Share, Basic -1.41 USD/shares -93%
Earnings Per Share, Diluted -1.41 USD/shares -93%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,882,498 USD -91%
Cash, Cash Equivalents, and Short-term Investments $25,737,221 USD
Other Assets, Current $852,036 USD -61%
Assets, Current $27,094,147 USD -62%
Property, Plant and Equipment, Net $898,930 USD -37%
Operating Lease, Right-of-Use Asset $266,646 USD -41%
Other Assets, Noncurrent $53,910 USD 0%
Assets $28,313,633 USD -61%
Accounts Payable, Current $2,033,431 USD 257%
Employee-related Liabilities, Current $1,269,474 USD 14%
Liabilities, Current $8,205,459 USD 89%
Operating Lease, Liability, Noncurrent $83,999 USD -69%
Liabilities $8,289,458 USD 80%
Retained Earnings (Accumulated Deficit) $186,874,486 USD -43%
Stockholders' Equity Attributable to Parent $20,024,175 USD -71%
Liabilities and Equity $28,313,633 USD -61%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $9,185,480 USD -95%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $12,808,962 USD -1222%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 33,378,139 shares 7.8%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $21,994,442 USD -127%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,882,498 USD -91%
Interest Paid, Excluding Capitalized Interest, Operating Activities $126,027 USD 2848%
Deferred Tax Assets, Valuation Allowance $74,334,787 USD 9.7%
Deferred Tax Assets, Gross $74,390,783 USD 9.7%
Operating Lease, Liability $273,646 USD -40%
Depreciation $27,560 USD -17%
Payments to Acquire Property, Plant, and Equipment $6,312 USD 98%
Lessee, Operating Lease, Liability, to be Paid $288,812 USD -43%
Property, Plant and Equipment, Gross $1,672,577 USD 0.38%
Operating Lease, Liability, Current $189,647 USD 4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $202,876 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $215,127 USD 108%
Operating Lease, Weighted Average Discount Rate, Percent 0.1075 pure -5.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $15,166 USD -69%
Lessee, Operating Lease, Liability, to be Paid, Year Three $85,936 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $50,218,210 USD 21%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200,000 shares 0%
Unrecognized Tax Benefits $14,532,020 USD 53%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $177,379 USD 544%
Deferred Tax Assets, Net of Valuation Allowance $55,996 USD -41%
Share-based Payment Arrangement, Expense $7,767,694 USD -6.6%
Interest Expense $1,324,810 USD 173%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%